Venus Remedies gallops on winning WHO GDP certification

Image
Capital Market
Last Updated : Mar 09 2022 | 12:31 PM IST

Venus Remedies rose 3.79% to Rs 282.25 after the company said it won WHO Good Distribution Practices (GDP) certification for quality services across entire supply chain.

Venus Remedies has received the certification from SociGale de Surveillance (SGS), the world's leading testing inspection and certification company, in an endorsement of its quality services throughout the entire supply chain cycle.

The company said it has consistently maintained impeccable standards in its distribution operations and processes through proven quality management systems.

SGS awarded the WHO GDP certification to Venus Remedies following an elaborate audit. Internationally accepted pharmaceutical GDP regulations stipulate that distributors of pharmaceutical products and warehouses must align their operations with the specified standards.

The firm said it has adopted a 360-degree customer-centric approach to increase transparency and efficiency in the pharmaceutical supply chain. It has gone for process upgradation with digital marketplaces for online ordering, real-time order tracking. payment reconciliation and live chat support. The company has adopted IoT technologies to expand the reach of products to stockists/retailers directly and track shipments, along with essential data points like temperature, humidity and anti-tampering alarms in real time. It has developed proprietary warehousing algorithms for cartonisation and shipper-selection to reduce shipping and delivery time to half.

Having more than 25 Good Manufacturing Practices (GMP) approvals for its globally benchmarked manufacturing facilities, Venus Remedies has also been accredited with the Good Laboratory Practices (GLP) certification for its research center.

Venus Remedies is among the leading injectable manufacturers in the world. Net profit of Venus Remedies declined 51.54% to Rs 5.65 crore on 1.97% rise in net sales to Rs 124.34 crore in Q3 December 2021 over Q3 December 2020.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 09 2022 | 12:20 PM IST

Next Story